BE894825A - Complexes d'inclusion de steroides avec de la alpha-cyclodextrine procede pour leur preparation et compositions pharmaceutiques les contenant - Google Patents
Complexes d'inclusion de steroides avec de la alpha-cyclodextrine procede pour leur preparation et compositions pharmaceutiques les contenantInfo
- Publication number
- BE894825A BE894825A BE0/209341A BE209341A BE894825A BE 894825 A BE894825 A BE 894825A BE 0/209341 A BE0/209341 A BE 0/209341A BE 209341 A BE209341 A BE 209341A BE 894825 A BE894825 A BE 894825A
- Authority
- BE
- Belgium
- Prior art keywords
- steroid
- alpha
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 title 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 title 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003431 steroids Chemical class 0.000 title 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/001—Lactones
- C07J21/003—Lactones at position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nanotechnology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU813147A HU190356B (en) | 1981-10-27 | 1981-10-27 | Process for preparing steroid-gamma-cyclodextrin inclusion complexes with high water-solubility |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE894825A true BE894825A (fr) | 1983-02-14 |
Family
ID=10962794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE0/209341A BE894825A (fr) | 1981-10-27 | 1982-10-27 | Complexes d'inclusion de steroides avec de la alpha-cyclodextrine procede pour leur preparation et compositions pharmaceutiques les contenant |
Country Status (12)
| Country | Link |
|---|---|
| JP (1) | JPS5883699A (it) |
| BE (1) | BE894825A (it) |
| DD (1) | DD208549A5 (it) |
| DE (1) | DE3238800A1 (it) |
| DK (1) | DK474782A (it) |
| ES (1) | ES8308571A1 (it) |
| FR (1) | FR2515187A1 (it) |
| GB (1) | GB2109381A (it) |
| HU (1) | HU190356B (it) |
| IT (1) | IT1191049B (it) |
| NL (1) | NL8204122A (it) |
| SE (1) | SE8206055L (it) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU196230B (en) * | 1983-12-29 | 1988-10-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing water-soluble forms of polyene antibiotics and pharmaceutics comprising such active ingredient and plant protective with antifungal effect |
| GB2162529B (en) * | 1984-06-08 | 1988-03-02 | Nitrokemia Ipartelepek | B-cyclodextrin complex of benzene sulphonyl urea derivatives |
| US5223295A (en) * | 1988-01-22 | 1993-06-29 | Asterol International | Process for the elimination of steroid compounds contained in substance of biological origin |
| EP0381747A4 (en) * | 1988-08-15 | 1991-09-11 | American Maize-Products Company | Water soluble branched beta cyclodextrin steroid complex |
| US5229370A (en) * | 1988-08-15 | 1993-07-20 | Ammeraal Robert N | Water soluble branched beta cyclodextrin steroid complex |
| CA2087452A1 (en) * | 1991-05-20 | 1992-11-21 | Toshiro Tsuda | Steriod compound combined with polysaccharide |
| US20040152664A1 (en) * | 1998-09-02 | 2004-08-05 | Allergan, Inc. | Prednisolone compositions |
| DE60122764T2 (de) * | 2000-11-02 | 2007-10-11 | N.V. Organon | Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen |
| EP1216712A1 (en) * | 2000-12-20 | 2002-06-26 | Schering Aktiengesellschaft | Cyclodextrin-drospirenone inclusion complexes |
| EP1216713A1 (en) | 2000-12-20 | 2002-06-26 | Schering Aktiengesellschaft | Compositions of estrogen-cyclodextrin complexes |
| EP1353699B1 (en) * | 2000-12-20 | 2012-02-01 | Bayer Pharma Aktiengesellschaft | Beta-cyclodextrin-drospirenone inclusion complexes |
| US20070020298A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid |
| US20070020299A1 (en) | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| EP2825567A2 (en) * | 2012-03-13 | 2015-01-21 | Amphidex A/S | Production of stabilized channel type cyclodextrin crystals |
-
1981
- 1981-10-27 HU HU813147A patent/HU190356B/hu not_active IP Right Cessation
-
1982
- 1982-10-20 DE DE19823238800 patent/DE3238800A1/de not_active Withdrawn
- 1982-10-25 SE SE8206055A patent/SE8206055L/xx not_active Application Discontinuation
- 1982-10-26 IT IT23942/82A patent/IT1191049B/it active
- 1982-10-26 GB GB08230513A patent/GB2109381A/en not_active Withdrawn
- 1982-10-26 DD DD82244272A patent/DD208549A5/de unknown
- 1982-10-26 ES ES516840A patent/ES8308571A1/es not_active Expired
- 1982-10-26 NL NL8204122A patent/NL8204122A/nl not_active Application Discontinuation
- 1982-10-26 DK DK474782A patent/DK474782A/da not_active Application Discontinuation
- 1982-10-26 FR FR8217943A patent/FR2515187A1/fr not_active Withdrawn
- 1982-10-27 BE BE0/209341A patent/BE894825A/fr not_active IP Right Cessation
- 1982-10-27 JP JP57187658A patent/JPS5883699A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IT8223942A0 (it) | 1982-10-26 |
| NL8204122A (nl) | 1983-05-16 |
| DE3238800A1 (de) | 1983-05-05 |
| DK474782A (da) | 1983-04-28 |
| ES516840A0 (es) | 1983-09-16 |
| SE8206055L (sv) | 1983-04-28 |
| GB2109381A (en) | 1983-06-02 |
| SE8206055D0 (sv) | 1982-10-25 |
| IT1191049B (it) | 1988-02-24 |
| ES8308571A1 (es) | 1983-09-16 |
| FR2515187A1 (fr) | 1983-04-29 |
| HU190356B (en) | 1986-08-28 |
| DD208549A5 (de) | 1984-04-04 |
| JPS5883699A (ja) | 1983-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE896986A (fr) | Derives d'indole, procedes pour leur preparation et composition pharmaceutiques les contenant | |
| FR2595351B1 (fr) | Derives d'indole, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| PT77488A (fr) | Procede de preparation de derives de phenyl-1-piperidino-2-propanol et de compositions pharmaceutiques les contenant | |
| BE890574A (fr) | Derive d'aminoalcoyl-furanne, procede pour sa preparation et composition pharmaceutique le contenant | |
| FR2542740B1 (fr) | Derives de thiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| BE894825A (fr) | Complexes d'inclusion de steroides avec de la alpha-cyclodextrine procede pour leur preparation et compositions pharmaceutiques les contenant | |
| FR2411839B1 (fr) | Derives de l'acide cephalosporanique, procedes pour leur preparation et composition pharmaceutique les contenant | |
| FR2574793B1 (fr) | Composes derives d'indole, compositions pharmaceutiques les contenant et procede pour leur preparation | |
| BE894927A (fr) | Derives de l'ergoline, procede pour leur preparation et medicaments les contenant | |
| PT73763A (fr) | Procede pour la preparation de nouveaux epoxides d'alkaloides benzofenantridiniques et de compositions pharmaceutiques qui les contiennent | |
| PT74651B (fr) | Procede de preparation de derives de pyridine et de compositions pharmaceutiques les contenant | |
| FR2563519B1 (fr) | Derives d'iminothiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| BE885633A (fr) | Derives de 1,2,4-oxadiazolin-5-one, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| BE884101A (fr) | Derives d'isoquinoleine contenant du soufre, procedes pour leur preparation et composition pharmaceutiques les contenant | |
| FR2513994B1 (fr) | Tripeptides anorexigenes, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| PT75868A (fr) | Procede de preparation de derives benzylideniques et de compositions pharmaceutiques les contenant | |
| FR2315910A1 (fr) | Compositions pharmaceutiques contenant de la " debrycine " heterocolloidale et procede pour leur preparation | |
| MA19602A1 (fr) | Composes d'amino-oxazolyle, procede pour leur preparation, preparations pharmaceutiques qui contiennent ces composes, et leur application | |
| PT77767B (fr) | Procede de preparation de 3',5'-diarabinosides et de compositi-ons pharmaceutiques les contenant | |
| FR2551440B1 (fr) | Aminocyclopentanes, leur procede de preparation et compositions pharmaceutiques les contenant | |
| FR2529551B1 (fr) | Derives d'eburnane-oxime, procede pour leur preparation et compositions pharmaceutiques contenant ces composes | |
| FR2529549B1 (fr) | Oxime-ethers d'eburnane, procede pour leur preparation et compositions pharmaceutiques qui les contiennent | |
| FR2560193B1 (fr) | Derives d'aminodiaryl sulfoxyde, procede pour leur preparation et compositions pharmaceutiques et pesticides les contenant | |
| FR2529550B1 (fr) | Derives d'acide apovincaminique, procede pour leur preparation et compositions pharmaceutiques contenant ces derives | |
| FR2517672B1 (fr) | Thioalcanoyl-carnitines, procede pour leur preparation et composition pharmaceutique les contenant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: RICHTER GEDEON VEGYESZETI GYAR R.T. Effective date: 19841027 |